Research

Electronic Clinical Decision Support for Middle Eastern Hospitals

Hospitals in the Middle East are set to benefit from sophisticated electronic clinical decision support following the commercial agreement between First DataBank International (FDB International) and GE Healthcare (GE). This agreement builds on the relationship which First DataBank has with GE Healthcare's Information Technology business in the US.

Novel Drug for Chronic Management of Hyperuricemia in Gout Patients

Teijin Pharma Limited announced the European launch of TMX-67 (febuxostat), a novel drug discovered by Teijin Pharma for the treatment of hyperuricemia in patients with gout. Ipsen, a global biotechnology specialty care group and the TMX-67 licensee in Europe, and its sublicensee the Menarini Group, the first Italian pharmaceutical group in the world, have began marketing the product in Europe under the brand name ADENURIC(r).

Synthon completes acquisition of Nafar Laboratorios

Synthon announces its acquisition of Nafar Laboratorios - a developer, manufacturer and distributor of generic drugs to the Mexican market. Nafar has grown from a distributor of generic drugs broadly to an integrated company with its own research and development capabilities.

MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALS

Trophos, the pharmaceutical company specialising in therapies for orphan diseases including ALS (also known as Lou Gehrig's disease), announces, on behalf of the MitoTarget consortium, the launch of MitoTarget Online. The multilingual web-based resource aims to be the first point of call for all of those affected by ALS. This includes sufferers and all physicians, care nurses and specialists, as well as members of the public with a friend or family member with the disease.

EU-funded researchers sequence human gut microbe genome

EU-funded researchers have sequenced the genome of the community of microbes that lives in our guts. The study sheds new light on the influence of these microbes on our health and could lead to the development of new treatments and diagnostic tests for a variety of diseases.

Powerful Universal Search Engine Makes Scientific Research Easy to Find

Scientists across the world now have access to a powerful new tool not just to present their research, but also to have it discovered by a global audience. No longer do researchers or smaller labs have to worry about their hard work going unnoticed by other scientists, or have to feel restricted to print journals to communicate their ideas. ScienceStage.com has recently unveiled its universal search engine and recommender system, which intelligently link all scientific multimedia content found both on its website and on external scientific databases. Science 2.0 is entering the orbit of Web 3.0.

Good news for young type 2 diabetics

There may be hope for young adults suffering from type 2 diabetes, according to new research. Writing in the journal Diabetes Care, the researchers from Ireland, Spain and Italy investigated how new mechanisms in muscle cells may elucidate severe insulin resistance in the body, and showed a reduced response to aerobic exercise in young obese patients with type 2 diabetes.

Research & Development

Electronic Clinical Decision Support for Middle Eastern Hospitals

Novel Drug for Chronic Management of Hyperuricemia in Gout Patients

Synthon completes acquisition of Nafar Laboratorios

MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALS

EU-funded researchers sequence human gut microbe genome

Powerful Universal Search Engine Makes Scientific Research Easy to Find

Good news for young type 2 diabetics

More Pharma News ...